Alecensa capsule 150mg (Alectinib) from Chugai Pharmaceutical, YJ code 4291032M3021 (150mg 1 capsule), is a kinase inhibitor used to treat adults with ALK-positive non-small cell lung cancer (NSCLC), both in metastatic cases and as adjuvant treatment after tumor resection.
Alecensa capsule 150mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
